Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Régis Bordet

Showing results (1-10 of 233) with videos related to

Pageof 24
Sort By:
Therapie|April 11, 2015
Addiction, experimental models and neurobiological mechanismsRégis Bordet
Therapie|February 16, 2021
Contributions of animal models of cognitive disorders to neuropsychopharmacologyJulie Deguil, Régis Bordet
Therapie|March 5, 2008
Neuroprotection: Present and futureRégis Bordet, Pierre Lestage, Brigitte Onteniente, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|March 26, 2019
[Epidemiology of neurocognitive disorders in France]Michaël Rochoy, Emmanuel Chazard, Régis Bordet
Psychopharmacology|July 28, 2010
Fetal alcohol-induced hyperactivity is reversed by treatment with the PPARα agonist fenofibrate in a rat modelKévin Marche, Thierry Danel, Régis Bordet
Therapie|August 13, 2009
Relevance of the evaluation criteria used in clinical trials for Alzheimer's diseasePhilippe Truffinet, Régis Bordet, Joël Ménard
Medical Hypotheses|March 23, 2007
The strange case of Dr HDL and Mr HDL: does a NO's story illuminate the mystery of HDL's dark side uncovered by Dr HDL's drug targeting CETP?Patrick Duriez, Régis Bordet, Pascal Berthelot
Therapie|March 14, 2007
Medical pharmacology: from review to planningRégis Bordet, Pascale Jolliet, Patrice Jaillon
Therapie|November 1, 2012
Personalized Medicine: how to Switch from the Concept to the Integration into the Clinical Development Plan to Obtain Marketing AuthorizationLaurent Becquemont, Régis Bordet, Dominic Cellier, et al.
Behavioural Brain Research|January 18, 2011
Brain ischemia changes the long term response to antidepressant drugs in miceDominique Deplanque, Venugopal Reddy Venna, Régis Bordet
Pageof 24

Showing results (1-10 of 233) with videos related to

Sort By:
Pageof 24
Therapie|April 11, 2015
Addiction, experimental models and neurobiological mechanismsRégis Bordet
Therapie|February 16, 2021
Contributions of animal models of cognitive disorders to neuropsychopharmacologyJulie Deguil, Régis Bordet
Therapie|March 5, 2008
Neuroprotection: Present and futureRégis Bordet, Pierre Lestage, Brigitte Onteniente, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|March 26, 2019
[Epidemiology of neurocognitive disorders in France]Michaël Rochoy, Emmanuel Chazard, Régis Bordet
Psychopharmacology|July 28, 2010
Fetal alcohol-induced hyperactivity is reversed by treatment with the PPARα agonist fenofibrate in a rat modelKévin Marche, Thierry Danel, Régis Bordet
Therapie|August 13, 2009
Relevance of the evaluation criteria used in clinical trials for Alzheimer's diseasePhilippe Truffinet, Régis Bordet, Joël Ménard
Medical Hypotheses|March 23, 2007
The strange case of Dr HDL and Mr HDL: does a NO's story illuminate the mystery of HDL's dark side uncovered by Dr HDL's drug targeting CETP?Patrick Duriez, Régis Bordet, Pascal Berthelot
Therapie|March 14, 2007
Medical pharmacology: from review to planningRégis Bordet, Pascale Jolliet, Patrice Jaillon
Therapie|November 1, 2012
Personalized Medicine: how to Switch from the Concept to the Integration into the Clinical Development Plan to Obtain Marketing AuthorizationLaurent Becquemont, Régis Bordet, Dominic Cellier, et al.
Behavioural Brain Research|January 18, 2011
Brain ischemia changes the long term response to antidepressant drugs in miceDominique Deplanque, Venugopal Reddy Venna, Régis Bordet
Pageof 24